← Back to All Filings

Natera Director Matthew Rabinowitz Files Form 144 for 722 Shares

Low SignificanceNovember 2, 2026 at 4:46:47 PM EST

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📈 Form 144 Notice of Proposed Sale Company: Natera, Inc. (NTRA) Insider: Matthew Rabinowitz (Director) Shares to Sell: 722 Common Stock Est. Value: $299,124.60 (~$414.30/share) Broker: E*TRADE Corporation Source: Restricted Stock Units vested on 10/31/2026

Comprehensive Analysis

Executive Summary

On November 2, 2026, Matthew Rabinowitz, Director and Co-Founder of Natera, Inc. (NASDAQ: NTRA), filed Form 144 indicating an intention to sell 722 shares of common stock with an aggregate market value of approximately $299,124.60 via E*TRADE Corporation.

Transaction Details

  • Securities Class: Common Stock
  • Proposed Sale Volume: 722 shares
  • Aggregate Market Value: $299,124.60 (implied price of ~$414.30 per share)
  • Shares Outstanding: 144,144,170 shares
  • Acquisition Origin: The shares were acquired upon the vesting of Restricted Stock Units (RSUs) on October 31, 2026, as compensation for services rendered.

Prior 3-Month Activity

The filing discloses significant prior sales by Dr. Rabinowitz over the preceding three months:

  • 10/27/2026: 1,718 shares for $732,452.12
  • 10/15/2026: 50,000 shares for $20,132,190.00
  • 09/15/2026: 50,000 shares for $17,359,280.00
  • 09/14/2026: 50,000 shares for $16,737,975.00
  • 09/11/2026: 50,000 shares for $16,398,265.00
  • 08/03/2026: 731 shares for $195,900.21

Assessment

The 722 proposed shares represent a negligible fraction of the company's outstanding float (<0.001%) and appear to correspond to routine RSU vesting activity (potentially sell-to-cover or standard post-vesting monetization). As such, this planned sale carries low market significance.

Topics:#Natera#NTRA#Form144#InsiderTrading#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.